TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 23 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 39,820 | $119,000 | 0.02% |
| Westside Investment Management, Inc. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $69 | 0.00% |
| JPMORGAN CHASE & CO | 78 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 17 | $0 | 0.00% |
| VANGUARD GROUP INC | 72,791 | $217,000 | 0.00% |
| UBS Group AG | 23,459 | $70,000 | 0.00% |
| Sowell Financial Services LLC | 19 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 15 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 138 | $0 | 0.00% |